federal register • 01 april 2019

Posted on by

CMS has published in the federal register:

  • A Final Rule for the Medicaid Program: Covered Outpatient Drug; Line Extension Definition; and Change to the Rebate Calculation for Line Extension Drugs
  • A Notice for the Medicare and Medicaid Programs: Application from the American Association for Accreditation of Ambulatory Surgery Facilities, Inc. for its Outpatient Physical Therapy and Speech Language Pathology Services Accreditation Program
  • A Notice for the Medicare Program: Meeting Announcement for the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests
  • Notice of a Public Meeting on June 24, 2019 Regarding New and Reconsidered Clinical Diagnostic Laboratory Test Codes for the Clinical Laboratory Fee Schedule for Calendar Year 2020

federal register • 29 march 2019

Posted on by

CMS has published in the federal register:

  • A Notice for the Medicare Program: Approval of the Accreditation Association for Hospitals and Health Systems/Healthcare Facilities Accreditation Program (formerly known as the American Osteopathic Association/Healthcare Facilities Accreditation Program) as an Accreditation Organization under the Clinical Laboratory Improvement Amendments of 1988

federal register • 28 march 2019

Posted on by

CMS has published in the federal register:

  • Notice of Agency Information Collection Activities:
    1. ICF/IID Survey Report Form and Supporting Regulations
    2. Initial and Renewal Model of Care Submissions Off-cycle Submission of Summaries of Model of Care
  • Notice of Agency Information Collection Activities: Medicare Part C and Part D Data Validation (42 CFR 422.516g and 423.514g)

federal register • 31 january 2019

Posted on by

CMS has published in the federal register:

  • A Correction to Final Rules for the Medicare Program:
    1. Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2019;
    2. Medicare Shared Savings Program Requirements;
    3. Quality Payment Program;
    4. Medicaid Promoting Interoperability Program;
    5. Quality Payment Program-Extreme and Uncontrollable Circumstance Policy for the 2019 MIPS Payment Year;
    6. Provisions From the Medicare Shared Savings Program-Accountable Care Organizations Pathways to Success; and
    7. Expanding the Use of Telehealth Services for the Treatment of Opioid Use Disorder Under the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act
  • A Notice of Agency Information Collection Activities:
    1. Enrollment Opportunity Notice Relating to Lifetime Limits; Required Notice of Rescission of Coverage; and Disclosure Requirements for Patient Protection under the Affordable Care Act
    2. Medicare Advantage Qualifying Payment Arrangement Incentive (MAQI) Demonstration
    3. The Fiscal Soundness Reporting Requirements
    4. Information Collection Requirements for Compliance with Individual and Group Market Reforms under Title XXVII of the Public Health Service Act
    5. Prepaid Health Plan Cost Report
    6. Testing of Web Survey Design and Administration for CMS Experience of Care Surveys
    7. Medicare Current Beneficiary Survey
  • A Notice of Agency Information Collection Activities:
    1. Contract Year 2020 Plan Benefit Package (PBP) Software and Formulary Submission
    2. Federal Qualified Health Center Cost Report
    3. Prospective Payments for Hospital Outpatient Services
    4. Medicare EDI Enrollment Form and EDI Registration
    5. Hospitals and Health Care Complex Cost Report
    6. Use of Restraint and Seclusion in Psychiatric Residential Treatment Facilities (PRTFs) for Individuals Under Age 21 and Supporting Regulations
    7. 21st Century Cures Act Section 12002 IMD Study
    8. Medicare Advantage Application—Part C and 1876 Cost Plan Expansion Application Regulations under 42 CFR 422 (Subpart K) & 417.400
    9. Medicare Program; Prior Authorization Process for Certain Durable Medical Equipment, Prosthetic, Orthotics, and Supplies (DMEPOS)
    10. Medicare Coverage of Items and Services in FDA Investigational Device Exemption Clinical Studies—Revision of Medicare Coverage

federal register • 23 november 2018

Posted on by

CMS has published in the federal register:

  • A Final Rule for the Medicare Program:
    1. Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2019;
    2. Medicare Shared Savings Program Requirements;
    3. Quality Payment Program;
    4. Medicaid Promoting Interoperability Program;
    5. Quality Payment Program-Extreme and Uncontrollable Circumstance Policy for the 2019 MIPS Payment Year;
    6. Provisions From the Medicare Shared Savings Program-Accountable Care Organizations-Pathways to Success; and
    7. Expanding the Use of Telehealth Services for the Treatment of Opioid Use Disorder Under the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act

federal register • 14 november 2018

Posted on by

CMS has published in the federal register:

  • A Final Rule for the Medicare Program:
    1. End-Stage Renal Disease Prospective Payment System,
    2. Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury,
    3. End-Stage Renal Disease Quality Incentive Program,
    4. Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) and Fee Schedule Amounts, and
    5. Technical Amendments to Correct Existing Regulations Related to the CBP for Certain DMEPOS
  • A Proposed Rule for the Medicaid Program: Medicaid and Childrens Health Insurance Plan Managed Care